Annual report pursuant to Section 13 and 15(d)

Note 8 - Stockholders' Deficiency: Recapitalization (Details)

v3.20.1
Note 8 - Stockholders' Deficiency: Recapitalization (Details) - shares
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Common Stock, Shares Authorized 1,200,000,000 700,000,000
Transaction 1    
Sale of Stock, Transaction Date May 01, 2019  
Common Stock, Shares Authorized 1,200,000,000